STATUS OF PHARMACOVIGILANCE PROGRAM OF INDIA
73 / 108
Abstract
Nil
Downloads
References
1. Ballari Brahmachari, Melanie Fernandes, and Arun Bhatt Pharmacovigilance for clinical trials in India: Current practice and areas for reform. Perspect Clin Res. 2011 Apr- Jun; 2(2): 49–53.
2. Furlan G. Drug Saf.Using resources for scientific-driven pharmacovigilance: from many product safety documents to one product safety master file. 2012 Aug 1;35(8):615-22.
3. Bailey S1, Singh A, Azadian R, Huber P, Blum M.Drug Saf.Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles. 2010 Feb 1;33(2):139-46
Downloads
Published
Issue
Section
License
All the copy right belongs to the sponsoring Organization, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 51.